The association of plasma lactate with incident cardiovascular outcomes

American Journal of Epidemiology

Volumn 178, Issue 3, 2013, Pages 401-409

  Matsushita, Kunihiro ^a   Williams, Emma K ^a   Mongraw Chaffin, Morgana L ^a   Coresh, Josef ^a   Schmidt, Maria Ines ^b   Brancati, Frederick L ^c   Hoogeveen, Ron C ^d   Ballantyne, Christie M ^d   Young, J Hunter ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cardiovascular disease; epidemiology; heart failure; oxidative capacity; plasma lactate

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LACTIC ACID;

CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; MORTALITY; NITROGEN; NUMERICAL MODEL; OXIDATION; PLASMA; RISK FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE;

CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; HEART FAILURE; OXIDATIVE CAPACITY; PLASMA LACTATE;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; COMMUNITY-BASED PARTICIPATORY RESEARCH; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; LACTIC ACID; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; SMOKING; STROKE; SURVIVAL RATE; UNITED STATES;

EID: 84881169449     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt002     Document Type: Article

References (45)

1. Linnane A, Ozawa T, Marzuki S, et al. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1989;333(8639):642-645.
2. Bernal-Mizrachi C, Semenkovich CF. Fast predators or fast food, the fit still survive. Nat Med. 2006;12(1):46-47.
3. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-273.
4. Wisloff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005;307(5708):418-420.
5. Bruce CR, Anderson MJ, Carey AL, et al. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab. 2003;88(11):5444-5451.
6. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300(5622):1140-1142.
7. Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115(12): 3587-3593.
8. Sparks LM, Xie H, Koza RA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes. 2005;54(7):1926-1933.
9. Kelley DE, He J, Menshikova EV, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944-2950.
10. Crawford SO, Ambrose MS, Hoogeveen RC, et al. Association of lactate with blood pressure before and after rapid weight loss. Am J Hypertens. 2008;21(12):1337-1342.
11. Zagari F, Jordan M, Stettler M, et al. Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity. N Biotechnol. 2013;30(2):238-245.
12. DiGirolamo M, Newby FD, Lovejoy J. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J. 1992;6(7):2405-2412.
13. Doar JW, Wynn V, Cramp DG. Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metabolism. 1968; 17(8):690-701.
14. Jansson PA, Larsson A, Lönnroth PN. Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1998;28(10):813-818.
15. Baron AD, Brechtel-Hook G, Johnson A, et al. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. 1993;21(2): 129-135.
16. The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
17. Eriksson H, Caidaul K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea ? validation of a scoring test for clinical-epidemiological use: The Study of Men Born in 1913. Eur Heart J. 1987;8(9):1007-1014.
18. Wilhelmsen L, Eriksson H, Svardsudd K, et al. Improving the detection and diagnosis of congestive heart failure. Eur Heart J. 1989;10(suppl C):13-18.
19. Evenson KR, Rosamond WD, Cai J, et al. Physical activity and ischemic stroke risk. The Atherosclerosis Risk in Communities Study. Stroke. 1999;30(7):1333-1339.
20. Houston DK, Stevens J, Cai J. Abdominal fat distribution and functional limitations and disability in a biracial cohort: the Atherosclerosis Risk in Communities Study. Int J Obes (Lond). 2005;29(12):1457-1463.
21. Papp AC, Hatzakis H, Bracey A, et al. ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61(1):15-19.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
23. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.
24. Olsen MH, Hansen TW, Christensen MK, et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity Creactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J. 2007;28(11):1374-1381.
25. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220.
26. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49(2):223-233.
27. Rathore SS, Hinn AR, Cooper LS, et al. Characterization of incident stroke signs and symptoms: findings from the atherosclerosis risk in communities study. Stroke. 2002; 33(11):2718-2721.
28. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30(4):736-743.
29. Matsushita K, Blecker S, Pazin-Filho A, et al. The association of hemoglobin A1c with incident heart failure among people without diabetes: the Atherosclerosis Risk in Communities Study. Diabetes. 2010;59(8):2020-2026.
30. Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011; 57(16):1690-1696.
31. Avery CL, Loehr LR, Baggett C, et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) Study. J Am Coll Cardiol. 2012;60(17):1640-1646.
32. D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753.
33. Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003;163(21):2594-2602.
34. Mizushima Y, Ueno M,Watanabe H, et al. Discrepancy between heart rate and makers of hypoperfusion is a predictor of mortality in trauma patients. J Trauma. 2011;71(4): 789-792.
35. Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med. 2009;37(10):2827-2839.
36. Tanaka H, Seals DR. Endurance exercise performance in Masters athletes: age-associated changes and underlying physiological mechanisms. J Physiol. 2008;586(1):55-63.
37. Loehr LR, Rosamond WD, Poole C, et al. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol. 2010;172(7):781-789.
38. Kern M. Coronary blood flow and myocardial ischemia. In: Zipes D, Libby P, Bonow R, Braunwald E, eds. Braunwald's Heart Disease: A Text Book of Cardiovascular Medicine. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005:1103-1127.
39. Canty J. Coronary blood flow and myocardial ischemia. In: Bonow R, Mann D, Zipes D, Libby P, eds. Braunwald's Heart Disease: A Text Book of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:1049-1075.
40. Berardo A, Musumeci O, Toscano A. Cardiological manifestations of mitochondrial respiratory chain disorders. Acta Myol. 2011;30(1):9-15.
41. Gupta A, Akki A, YibinW, et al. Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest. 2012;122(1):291-302.
42. Arboix A, Alio J. Acute cardioembolic stroke: an update. Expert Rev Cardiovasc Ther. 2011;9(3):367-379.
43. van Hall G. Lactate kinetics in human tissues at rest and during exercise. Acta Physiol (Oxf). 2010;199(4):499-508.
44. Guyette F, Suffoletto B, Castillo J-L, et al. Prehospital serum lactate as a predictor of outcomes in trauma patients: a retrospective observational study. J Trauma. 2011;70(4): 782-786.
45. Kessler KM, Kozlovskis P, Trohman RG, et al. Serum lactate: prognostic marker for recurrent cardiac arrest? Am Heart J. 1987;113(6):1540-1544.